Latest Headlines

Latest Headlines

NIH provides Great Basin Scientific and BYU $5M+ to develop rapid test for CRE

The National Institutes of Health has awarded more than $5 million over 5 years to diagnostics company Great Basin Scientific and Brigham Young University to develop a rapid molecular diagnostic test from whole blood for carbapenem-resistant Enterobacteriaceae (CRE).

NIH grants Northeastern prof $1.4M to address 'bottleneck' in vaccine development

The National Institutes of Health has awarded Northeastern professor of chemical engineering Shashi Murthy a four-year $1.4 million grant to develop a novel instrument that would ease a "tremendous bottleneck" in vaccine development.

Sanofi-Aventis to see slew of Plavix generics join Japan NHI reimbursement list

Japan's National Health Insurance (NHI) has confirmed that a slew of generic versions of Sanofi's Plavix will join the reimbursement list after the latest review, a move tipped by the company in its first-quarter earnings call as well.

NIH finds sand fly saliva may be the key to leishmaniasis vaccine

Researchers at the National Institutes of Health reported that a leishmaniasis vaccine based on sand fly saliva has worked well in monkeys. 

Shire's Vyvanse could bag another lucrative new market in menopausal women

Shire has been working hard to expand blockbuster Vyvanse beyond ADHD. And now, new research has suggested another avenue for doing just that.

Serious manufacturing issues tied to fungal contamination in NIH facility

The FDA, which has been going full bore after offending compounding pharmacies, has now turned its attention to one of its sister agencies. The result is that the National Institutes of Health has closed its Pharmaceutical Development Section after FDA inspectors found "serious manufacturing problems" that resulted in fungal contamination in a drug used in clinical trials.

NIH slams the brakes on drug production after contamination scare

The National Institutes of Health has halted production at a plant that makes drugs for clinical trials after discovering some alarming manufacturing mishaps, a move that affects 46 ongoing studies.

NIH advice on early HIV treatment could boost sales at Gilead, GSK, J&J and BMS

U.S. federal health officials said patients should take antiretroviral meds as soon as they are diagnosed instead of waiting to start therapy, potentially opening the door for increased sales of the drugs.

NIH funds 5 projects to treat blindness, unveils Alzheimer's research agenda

The U.S. National Institutes of Health's National Eye Institute is spending up to $17.9 million over the next 5 years to find new therapies for blindness. In addition, the NIH just unveiled its Alzheimer's disease research agenda.

Congress keeps trial data sharing plan in slimmed-down 21st Century Cures Act

Legislation that would mandate the creation of a system to share de-identified clinical trial data has moved a step closer to coming into force. The text is included in the latest draft of the 21st Century Cures Act, which is almost 200 pages shorter than the original proposal.